BH.IMMUN&BIO | UNICK FIX-A-FORM AND PRINTERS | BH.IMMUN&BIO/ UNICK FIX-A-FORM AND PRINTERS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -7.8 | 30.9 | - | View Chart |
P/BV | x | 1.5 | 1.3 | 119.6% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
BH.IMMUN&BIO UNICK FIX-A-FORM AND PRINTERS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
BH.IMMUN&BIO Mar-23 |
UNICK FIX-A-FORM AND PRINTERS Mar-23 |
BH.IMMUN&BIO/ UNICK FIX-A-FORM AND PRINTERS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 52 | 59 | 87.7% | |
Low | Rs | 21 | 32 | 65.1% | |
Sales per share (Unadj.) | Rs | 10.3 | 120.5 | 8.6% | |
Earnings per share (Unadj.) | Rs | -3.9 | 4.1 | -94.4% | |
Cash flow per share (Unadj.) | Rs | -3.8 | 11.2 | -33.9% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 20.4 | 53.9 | 37.9% | |
Shares outstanding (eoy) | m | 43.18 | 5.49 | 786.5% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 3.5 | 0.4 | 932.4% | |
Avg P/E ratio | x | -9.4 | 11.1 | -84.7% | |
P/CF ratio (eoy) | x | -9.5 | 4.0 | -235.5% | |
Price / Book Value ratio | x | 1.8 | 0.8 | 210.9% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 1,561 | 248 | 628.6% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 151 | 90 | 168.5% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 446 | 662 | 67.4% | |
Other income | Rs m | 11 | 5 | 207.4% | |
Total revenues | Rs m | 457 | 667 | 68.5% | |
Gross profit | Rs m | -161 | 88 | -183.1% | |
Depreciation | Rs m | 2 | 39 | 5.1% | |
Interest | Rs m | 71 | 24 | 296.4% | |
Profit before tax | Rs m | -223 | 30 | -745.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | -56 | 7 | -753.5% | |
Profit after tax | Rs m | -166 | 22 | -742.5% | |
Gross profit margin | % | -36.0 | 13.3 | -271.6% | |
Effective tax rate | % | 25.3 | 25.0 | 101.1% | |
Net profit margin | % | -37.3 | 3.4 | -1,101.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 358 | 301 | 119.0% | |
Current liabilities | Rs m | 940 | 287 | 327.8% | |
Net working cap to sales | % | -130.6 | 2.1 | -6,149.2% | |
Current ratio | x | 0.4 | 1.0 | 36.3% | |
Inventory Days | Days | 85 | 4 | 2,207.6% | |
Debtors Days | Days | 1,135 | 72,349,839 | 0.0% | |
Net fixed assets | Rs m | 1,262 | 402 | 314.2% | |
Share capital | Rs m | 432 | 55 | 787.2% | |
"Free" reserves | Rs m | 450 | 241 | 186.8% | |
Net worth | Rs m | 882 | 296 | 298.1% | |
Long term debt | Rs m | 0 | 89 | 0.0% | |
Total assets | Rs m | 1,620 | 705 | 229.6% | |
Interest coverage | x | -2.2 | 2.3 | -95.6% | |
Debt to equity ratio | x | 0 | 0.3 | 0.0% | |
Sales to assets ratio | x | 0.3 | 0.9 | 29.4% | |
Return on assets | % | -5.9 | 6.6 | -90.2% | |
Return on equity | % | -18.9 | 7.6 | -249.0% | |
Return on capital | % | -17.2 | 14.0 | -123.5% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 14.5 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | 65 | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 65 | 0 | - | |
Net fx | Rs m | -65 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 109 | 44 | 249.4% | |
From Investments | Rs m | 5 | -27 | -17.1% | |
From Financial Activity | Rs m | -147 | -16 | 902.6% | |
Net Cashflow | Rs m | -34 | 0 | -9,591.4% |
Indian Promoters | % | 59.3 | 71.6 | 82.8% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.5 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 40.8 | 28.4 | 143.3% | |
Shareholders | 35,313 | 1,622 | 2,177.1% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare BH.IMMUN&BIO With: DIVIS LABORATORIES SUN PHARMA CIPLA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | BH.IMMUN&BIO | UNICK FIX-A-FORM AND PRINTERS | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -1.02% | 3.79% | -0.51% |
1-Month | -6.87% | 15.61% | 1.44% |
1-Year | 35.05% | 69.64% | 52.10% |
3-Year CAGR | -20.53% | 29.15% | 12.94% |
5-Year CAGR | 30.42% | 26.74% | 21.48% |
* Compound Annual Growth Rate
Here are more details on the BH.IMMUN&BIO share price and the UNICK FIX-A-FORM AND PRINTERS share price.
Moving on to shareholding structures...
The promoters of BH.IMMUN&BIO hold a 59.3% stake in the company. In case of UNICK FIX-A-FORM AND PRINTERS the stake stands at 71.6%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BH.IMMUN&BIO and the shareholding pattern of UNICK FIX-A-FORM AND PRINTERS.
Finally, a word on dividends...
In the most recent financial year, BH.IMMUN&BIO paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.
UNICK FIX-A-FORM AND PRINTERS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of BH.IMMUN&BIO, and the dividend history of UNICK FIX-A-FORM AND PRINTERS.
For a sector overview, read our pharmaceuticals sector report.
After opening the day marginally higher, Indian share turned muted as the session progressed and ended the day flat.